Status:
ACTIVE_NOT_RECRUITING
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is the first non-traumatic cause of disability in young people, responsible for physical but also cognitive deficits. MS is an inflammatory demyelinating and degenerative disea...
Eligibility Criteria
Inclusion
- Major patient,
- Patient affiliated to a health insurance plan
- Patient having signed free and informed consent after receiving detailed, understandable and honest information,
- Patient with multiple sclerosis according to the criteria of Polman 2010
Exclusion
- Patients with the usual contraindications to MRI (pace-maker, agitation, metal splinters, claustrophobia etc.)
- Patients at risk of non-compliance on examination: impaired understanding, confusion, involuntary movements, poor tolerance of prolonged supine
- Patients with known allergy to gadolinium
- Patients with renal insufficiency
- Patients unable to give their consent: disorders of the comprehension, disturbances of vigilance, confusion ...
- Pregnant and breastfeeding woman
- Patients with a history of neurological or psychiatric pathology
- Patients under guardianship or curatorship
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2028
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03356366
Start Date
October 2 2017
End Date
December 31 2028
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hôpitaux de Marseille
Marseille, France, 13005